Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Young TIL Therapy for HPV-Associated Cancers
NCT01585428Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2012
- Primary completion
- Apr 2016
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of young tumor-infiltrating lymphocytes in Cervical Cancer (CC), oropharyngeal cancer, vaginal cancer, anal cancer, penile cancer, sponsored by National Cancer Institute. Started Apr 2012; status: completed.
02
Drugs
young tumor-infiltrating lymphocytes
03
Conditions
Cervical Cancer (CC)oropharyngeal cancervaginal canceranal cancerpenile cancer
Beyond the preview
Go deeper on NCT01585428.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01585428.